InflaRx

parasail Blue Lagoon parachute
Biotech

Abbvie's president adds COO title—Chutes & Ladders

AbbVie's president named COO. Emergent CEO Kramer retires a second time. Dunsire retires from Lundbeck after record quarter.
Max Bayer , Gabrielle Masson Jun 30, 2023 9:30am
COVID-19 danger coronavirus pandemic quarantine

InflaRx to take failed COVID treatment to FDA anyway

Jul 26, 2022 11:20am
europeGOOD

EuroBiotech Report—Lilly-CureVac, AstraZeneca-Brexit and more

Oct 19, 2017 11:21am
Spotlight

InflaRx snags $55M for inflammatory, autoimmune trials

Oct 13, 2017 9:47am
German flag

German startup raises $34M for first-in-class complement inhibitor

Jul 21, 2016 2:30pm